PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 232 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $406,477 | -34.4% | 41,435 | -44.2% | 0.29% | -38.4% |
| Q3 2023 | $619,954 | -58.0% | 74,246 | -33.2% | 0.48% | -50.9% |
| Q2 2023 | $1,477,776 | +21.7% | 111,111 | +5.9% | 0.97% | +13.7% |
| Q1 2023 | $1,214,684 | +42.2% | 104,895 | +0.4% | 0.85% | +20.2% |
| Q4 2022 | $854,000 | +40.5% | 104,458 | -0.3% | 0.71% | +37.7% |
| Q3 2022 | $608,000 | -67.5% | 104,770 | -75.2% | 0.52% | +20.0% |
| Q2 2022 | $1,869,000 | +473.3% | 422,836 | +1081.0% | 0.43% | +95.0% |
| Q1 2022 | $326,000 | -43.2% | 35,804 | +27.7% | 0.22% | -43.3% |
| Q4 2021 | $574,000 | -11.0% | 28,047 | +11.2% | 0.39% | -12.8% |
| Q3 2021 | $645,000 | -9.0% | 25,229 | +24.4% | 0.44% | -7.9% |
| Q2 2021 | $709,000 | – | 20,279 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |